← Leaderboards
Fares Qeadan
University Of Utah
$4,247,434
Attributed
$5,654,346
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,654,346 · 4
By mechanism
R01$3,543,978 · 2
R61$1,462,052 · 1
R33$648,316 · 1
Top collaborators
- Erin F Madden6 shared
- Kamilla L. Venner6 shared
Most similar at University Of Utah
Same institution · by research overlap
- Erin F Madden$1,789,818
- Sara Bybee$1,188,879
- Joseph Edward Tonna$2,248,526
- Tino S Nyawelo$1,138,492
- Marta L. McCrum$419,375
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsOpioid Use DisorderOpioid UseOpioid OverdoseOpioidNaltrexoneRaceAffectOverdoseCenters For Disease Control And Prevention (U.S.)BuprenorphineVariantExhibitsProceduresDatabasesProtective FactorsInterestMethadonePrescription OpioidCommunitiesDesignAreaDiagnosisHealth Care Facility
Grant awards (10)
Weighting Longitudinal Data to Access Opioid Analgesia Tapering Outcomes among Patients with Co-occurring Chronic Pain and Substance Use Disorder$680,457
R01 · FY2025 · DA · contact PI
Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder$648,316
R33 · FY2025 · DA · contact PI
Advancing Integrated Treatment for Co-Occurring Opioid and Alcohol Use Disorders: A Comprehensive Analysis of GLP-1 Receptor Agonists and Traditional Pharmacotherapies in Real-World Settings$385,000
R01 · FY2025 · AA · contact PI
Advancing Integrated Treatment for Co-Occurring Opioid and Alcohol Use Disorders: A Comprehensive Analysis of GLP-1 Receptor Agonists and Traditional Pharmacotherapies in Real-World Settings$385,000
R01 · FY2024 · AA · contact PI
Weighting Longitudinal Data to Access Opioid Analgesia Tapering Outcomes among Patients with Co-occurring Chronic Pain and Substance Use Disorder$2,093,521
R01 · FY2022 · DA · contact PI
Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder$606,504
R61 · FY2020 · DA · contact PI
The moderation effect of social support networks on the relationship between opioid use and suicide attempts among Native American youth in New Mexico$87,269
R61 · FY2020 · DA · contact PI
Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder$69,155
R61 · FY2020 · DA · contact PI
Modeling the role of modifiable risk and protective factors in opioid use disorder and non-fatal opioid overdose among AI/AN using EMR$45,229
R61 · FY2020 · DA · contact PI
Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology Center to Create Tribal Data and Culturally Center Medications for Opioid Use Disorder$653,895
R61 · FY2019 · DA · contact PI